openPR Logo
Press release

Growing Cancer Rates Propel Demand For Home-Based Chemotherapy Services: Transformative Forces Shaping the Chemotherapy At Home Services Market Landscape in 2025

08-05-2025 09:28 AM CET | Health & Medicine

Press release from: The Business Research Company

Chemotherapy At Home Services

Chemotherapy At Home Services

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Chemotherapy At Home Services Industry Market Size Be by 2025?
The market size for at-home chemotherapy services has witnessed a significant increase recently. It is projected to expand from $1.75 billion in 2024 to $1.95 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.5%. The historical growth rate can be linked to factors such as the rising occurrence of cancer, increasing preference among patients to obtain care at home, issues pertaining to hospital capacity, enhancements in home healthcare infrastructure, and favorable government policies.

What's the Long-Term Growth Forecast for the Chemotherapy At Home Services Market Size Through 2029?
The market size of home chemotherapy services is expected to experience swift expansion in the forthcoming years. It is projected to reach $2.97 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The anticipated growth throughout the forecast period can be linked to escalated healthcare expenses, an aging population, broadening of home healthcare services, amplified emphasis on patient-centric care, an increased inclination to decrease inpatient stays, and managing chronic diseases. Key trends in the forecast period consist of the incorporation of AI and machine learning, personalized healthcare procedures, wearable health technology, expansion of specialty home infusion services, and cooperative healthcare models.

View the full report here:
https://www.thebusinessresearchcompany.com/report/chemotherapy-at-home-services-global-market-report

What Are the Key Growth Drivers Fueling the Chemotherapy At Home Services Market Expansion?
The upsurge in cancer cases is predicted to boost the expansion of the market for chemotherapy-at-home services. Cancer, typified by unregulated proliferation and dissemination of aberrant cells in the human body, has become increasingly prevalent because of various causes, including aging populations, alterations in lifestyle, environmental factors, genetic propensities, and enhanced detection via sophisticated diagnostic procedures. Chemotherapy-at-home services provide the benefit for cancer patients to undergo treatment in their own homes, enhancing convenience and their standard of living. For example, in January 2023, The National Center for Biotechnology Information, a U.S. intergovernmental institution, reported that there were 1,958,310 fresh cancer incidents, and 609,820 cancer fatalities are estimated to occur in 2023 in the U.S. Therefore, the growing prevalence of cancer is contributing to the expansion of the market for chemotherapy-at-home services.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15762&type=smp

What Are the Key Trends Driving Chemotherapy At Home Services Market Growth?
Leading firms in the chemotherapy-at-home services market are pioneering novel ways to deliver chemotherapy care services, with the objective of elevating patient safety and comfort. This kind of service implies the administration of chemotherapy therapies in the familiar and convenient surroundings of a patient's home. For example, Jivika Healthcare, a mobile medical service corporation from India, rolled out ChemoAtHome, a home-based chemotherapy care service, in September 2022. The service is geared to deliver safe and top-notch cancer care, managed by competent nurses under the direction of an MBBS practitioner, where a hospital-like environment is established at the patient's residence. The main goal of ChemoAtHome is to offer comfort and financial savings, potentially reducing chemotherapy hospital costs by 20% to 25%. This service encompasses pre and post-chemotherapy support, including oncologist video consultations and door-step delivery of medicines.

How Is the Chemotherapy At Home Services Market Segmented?
The chemotherapy at home services market covered in this report is segmented -

1) By Product: Chemotherapy Drugs, Chemotherapy Infusion Pumps
2) By Administration: Oral, Intravenous
3) By Application: Breast Cancer, Blood Cancer, Ovarian Cancer, Colorectal Cancer

Subsegments:
1) By Chemotherapy Drugs: Oral Chemotherapy Drugs, Injectable Chemotherapy Drugs, Targeted Therapy Drugs, Chemotherapy Regimen Combinations
2) By Chemotherapy Infusion Pumps: Portable Infusion Pumps, Home Infusion Therapy Pumps, Electronic Infusion Pumps, Ambulatory Infusion Pumps

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15762&type=smp

Which Companies Are Leading the Charge in Chemotherapy At Home Services Market Innovation?
Major companies operating in the chemotherapy at home services market are CVS Health Corporation, Optum Inc., Fresenius Kabi, Medtronic plc, Amgen, Penn Medicine, Advocate Health Care, Medibank Private Limited, Option Care Health Inc., Amedisys Inc., Lincare Holdings Inc., Cancer Treatment Centers of America (CTCA), BioScrip Inc., Shanghai MicroPort Lifesciences Co. Ltd., Accredo Health Group Inc., LloydsPharmacy Clinical Homecare, InfuSystem Holdings Inc., Portea Medical, Amerita Inc., Jivika Healthcare, Vitalis Health and Home Care Pty Ltd., Ubiqare Health Pvt. Ltd., View Health Pty Ltd group, Sciensus Pharma Services Limited, TCP Homecare

Which Regions Are Leading the Global Chemotherapy At Home Services Market in Revenue?
North America was the largest region in the chemotherapy at-home services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemotherapy at home services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15762

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growing Cancer Rates Propel Demand For Home-Based Chemotherapy Services: Transformative Forces Shaping the Chemotherapy At Home Services Market Landscape in 2025 here

News-ID: 4133015 • Views:

More Releases from The Business Research Company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Forecast Report
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025? The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of
Sustained Release Excipients Market Advances With Product Innovation Industry Trends Gaining Momentum in the Global Sustained Release Excipients Market
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therapeutics Market Driving Market Acceleration in the RNA Targeting Small Molecules Therapeutics Industry, 2025
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025? In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as a Core Driver of the Remicade Biosimilar Market in 2025
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025? In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic

All 5 Releases


More Releases for Chemotherapy

Chemotherapy Devices Market - Innovation for Life: Chemotherapy Devices Driving …
Newark, New Castle, USA: The "Chemotherapy Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Chemotherapy Devices Market: https://www.growthplusreports.com/report/chemotherapy-devices-market/8623 This latest report researches the industry structure, sales, revenue,
Chemotherapy Devices Market 2022 Will Boom With Advanced Chemotherapy Technologi …
New Research Study ""Chemotherapy Devices Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook"" has been added to Coherent Market insight The most recent Global Chemotherapy Devices Market report includes a high-level overview of the industry as well as in-depth analysis of key areas. The overview presented highlights the definition of products and services, as well as their associated applications, at the
Cancer, chemotherapy and its treatment
Chemotherapy is one of the most commonly used cancer therapies. It employs the use of certain medications to destroy cancer cells or prevent them from spreading to other parts of the body. Chemotherapy may be prescribed alone or in combination with surgery or radiation therapy. Along with chemotherapy, you may also take newer types of cancer-fighting medications. Chemotherapy can be taken as pills or as injections. You may visit a clinic
Chemotherapy induced Nausea and Vomiting (CINV) TreatmentS Market Driven by Risi …
According to WHO cancer is one of the most leading causes for death with around 8 million deaths and 14 million new patients in 2012. Chemotherapy, which is received by approximately four million cancer patients each year, is among the most commonly used treatment to fight cancer. However, this mode of treatment has many side effects, an estimate of around 70% - 80% of the patients receiving chemotherapy treatment experience
Nano Chemotherapy Market Nano Chemotherapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Nano Chemotherapeutics Mediations andndash; Solicitation to Nanomedicine 1.1 Overview 1.2 Nano Chemotherapeutics with Pharmaceutical Potential Significance of Nano Chemotherapeutics to overcome the Chemotherapy Limitations 2.1 Limitations of Conventional Chemotherapy 2.2 Nanotechnology in Cancer Targeting 2.2.1 Active Targeting 2.2.2 Passive Targeting 2.2.3 pH Dependent Drug Delivery Through Nanoparticles Role
Nano Chemotherapy Is Emerging As An Important Anti-Cancer Modality By Supplement …
“Global Nano Chemotherapy Market and Clinical Trials Outlook 2022” report highlights the current development in the in the field of nano chemotherapy. Report gives comprehensive insight on various clinical and non-clinical parameters associated with the expansion of global nano chemotherapeutics market. The clinical and pricing insight on chemotherapeutics nanoformulations of approved drugs helps to understand the current market scenario of the nano chemotherapeutics. For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Download Report: